Akèy › Obèsite › Tennessee › Nashville
Etid klinik pou Obèsite nan Nashville, TN
17 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Clinical Research Associates - Nashville /ID# 282161, Nashville
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Ap rekriteFaz 2
- AMR Clinical, Nashville
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Ap rekriteFaz 3
- Vanderbilt Health One Hundred Oaks, Nashville
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Ap rekriteFaz 3
- Research Site, Franklin · 17 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- AMR Clinical, Nashville
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Quality Medical Research, Nashville
Transition to Ambulatory Bariatric Surgery (TABS) Trial
Ap rekrite
- Vanderbilt University Medical Center, Nashville
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- Clinical Research Associates, Nashville
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Nashville
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Quality Medical Research, Nashville
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
Ap rekriteFaz 1/2
- Vanderbilt University Medical Center, Nashville
Atomoxetine in Melanocortin Obesity Syndrome
Ap rekriteFaz 2
- Vanderbilt University Medical Center, Nashville
A Study to Improve Skeletal Muscle in Veterans With HIV
Ap rekrite
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Metabolic Effects of Angiotensin-(1-7)
Ap rekriteFaz 1
- Vanderbilt University Medical Center, Nashville
Sympathetic Mechanisms in Obesity-Crossover Design
Ap rekriteFaz 1/2
- Vanderbilt University Medical Center, Nashville
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Ap rekriteFaz 1/2Volontè an sante akeyi
- Vanderbilt University Medical Center (Part C only), Nashville
Tirzepatide in PWS, HO and GNSO
Ap rekriteFaz 4
- Vanderbilt University Medical Center, Nashville
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL31 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD25 etid
- Jacksonville, FL25 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete80 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat42 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.